While AI and robotics reshape our reality, experts explore how these emerging tools could be used to create a more equitable future – from healthcare breakthroughs to Indigenous-led innovation.
Common steroid treatments for the autoimmune disease lupus can cause as many problems as they solve, but researchers are close to finding a viable alternative.
An editorial team from the International Journal of Drug Policy has developed guiding principles to help researchers and academics avoid perpetuating stigma when writing about substance use.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
A team of scientists has developed an imaging technique to earlier detect abnormal collagen deposits in the heart, which causes a condition known as diffuse cardiac fibrosis.
It’s on the rise and affects people of all body sizes and genders, but binge-eating disorder is widely misunderstood and often ignored.
The issue of medicine-related harm is immense, and how to tackle it is an area of growing interest to governments and healthcare systems alike.
In a world first, researchers are harnessing data science to describe and predict when resistance to antibiotics will emerge during treatment for a bacterial infection.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Data from the Australian Institute of Criminology shows alarmingly high rates of sexual violence perpetration.
Nitazenes can be up to 50 times stronger than fentanyl. They’re not yet common in Australia, so now’s the time to implement policies to reduce their harm and limit their uptake.
Stigma within the healthcare system is being tackled head-on with the development of resources to help people with substance dependence access the care they need.
Some women who use drugs like Ozempic have reported unexpected pregnancies. What’s going on?
Researchers have completed Australia’s most detailed analysis of opioid tapering trajectories to date, with some findings that contradict current guidelines.
With the the psychedelic field dynamic and rapidly changing, Monash’s pioneering Clinical Psychedelic Lab has a vision to make a meaningful difference in mental healthcare.
A new trial is looking for chemical markers in the breath of people with silicosis. A second project will test drugs that may help lung scarring.
Government reforms are fighting the tactics that have fed a cultural acceptability of vaping, and a mistaken belief it has insignificant health risks.
The technology to link human brains with computers is developing quickly – but the path ahead is full of challenges.
With sperm counts declining worldwide, it’s important men know how to keep their sperm as healthy as possible.
Methotrexate is commonly used in Australia and around the world for conditions such as rheumatoid arthritis.
Antibiotics have been around for less than a century. But as resistant bacteria become increasingly difficult to treat, we risk a greater number of deaths from infections.
A new five-year study aims to build a broad picture of illicit drug use in regional Victoria, to better-understand the gaps in local health service planning.
Women are increasingly seeking testosterone therapy to treat fatigue and brain fog. But there’s no evidence it improves symptoms of menopause.
Discover how escapism, from TV to games, offers a vital break from daily life and fuels hope.
Dummy text
